HUP0101652A1 - Új kompozíció - Google Patents

Új kompozíció

Info

Publication number
HUP0101652A1
HUP0101652A1 HU0101652A HUP0101652A HUP0101652A1 HU P0101652 A1 HUP0101652 A1 HU P0101652A1 HU 0101652 A HU0101652 A HU 0101652A HU P0101652 A HUP0101652 A HU P0101652A HU P0101652 A1 HUP0101652 A1 HU P0101652A1
Authority
HU
Hungary
Prior art keywords
hepatitis
vaccine preparations
hepatitis vaccine
bantigen
vaccines
Prior art date
Application number
HU0101652A
Other languages
English (en)
Inventor
Claude Artois
Michael J. Clark
Clothilde Thiriart
Stefan Gabriel Jozef Thoelen
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of HUP0101652A1 publication Critical patent/HUP0101652A1/hu
Publication of HUP0101652A3 publication Critical patent/HUP0101652A3/hu
Publication of HU228209B1 publication Critical patent/HU228209B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A találmány új vakcina készítményekre vonatkozik, amelyek hepatitisz Bantigént tartalmaznak alumínium-foszfáttal kiszerelve. A vakcinakészítmények tartalmazhatnak továbbá inaktivált hepatitisz A vírust,alumínium-hidroxidot és formaldehidet. A kombinált hepatitisz A és Bvakcina készítmények, ha szükséges, beadhatók embernek 2 adagosadagolási rend szerint. Ó
HU0101652A 1998-05-01 1999-04-27 New composition HU228209B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition
PCT/EP1999/003024 WO1999056772A2 (en) 1998-05-01 1999-04-27 Hepatitis vaccine

Publications (3)

Publication Number Publication Date
HUP0101652A1 true HUP0101652A1 (hu) 2001-09-28
HUP0101652A3 HUP0101652A3 (en) 2004-10-28
HU228209B1 HU228209B1 (en) 2013-01-28

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101652A HU228209B1 (en) 1998-05-01 1999-04-27 New composition

Country Status (29)

Country Link
EP (1) EP1073462B1 (hu)
JP (2) JP5138843B2 (hu)
KR (1) KR100612547B1 (hu)
CN (1) CN1263509C (hu)
AR (1) AR016987A1 (hu)
AT (1) ATE345815T1 (hu)
AU (1) AU743759B2 (hu)
BR (1) BR9910157A (hu)
CA (1) CA2331086C (hu)
CO (1) CO5050367A1 (hu)
CY (1) CY1107322T1 (hu)
CZ (1) CZ301232B6 (hu)
DE (1) DE69934108T2 (hu)
DK (1) DK1073462T3 (hu)
ES (1) ES2277437T3 (hu)
GB (1) GB9809507D0 (hu)
GC (1) GC0000101A (hu)
HK (1) HK1034202A1 (hu)
HU (1) HU228209B1 (hu)
IL (1) IL139269A0 (hu)
MY (1) MY128929A (hu)
NO (1) NO20005483L (hu)
NZ (1) NZ507902A (hu)
PL (1) PL190729B1 (hu)
PT (1) PT1073462E (hu)
TR (1) TR200003235T2 (hu)
TW (1) TW553744B (hu)
WO (1) WO1999056772A2 (hu)
ZA (1) ZA200006118B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
PT835663E (pt) * 1992-05-23 2010-01-04 Glaxosmithkline Biolog Sa Vacinas combinadas compreendendo o antigénio de superfície da hepatite b e outros antigénios
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
US6372225B1 (en) * 1996-03-23 2002-04-16 The Research Foundation Of Microbial Diseases Of Osaka University Tetanus toxin functional fragment antigen and tetanus vaccine

Also Published As

Publication number Publication date
GB9809507D0 (en) 1998-07-01
EP1073462B1 (en) 2006-11-22
WO1999056772A3 (en) 2000-02-03
CN1308547A (zh) 2001-08-15
PL344137A1 (en) 2001-10-08
HUP0101652A3 (en) 2004-10-28
CO5050367A1 (es) 2001-06-27
ES2277437T3 (es) 2007-07-01
CA2331086C (en) 2010-06-22
BR9910157A (pt) 2001-01-09
JP5138843B2 (ja) 2013-02-06
DE69934108T2 (de) 2007-04-19
JP2002513771A (ja) 2002-05-14
PL190729B1 (pl) 2005-12-30
GC0000101A (en) 2005-06-29
EP1073462A2 (en) 2001-02-07
AR016987A1 (es) 2001-08-01
JP2010209118A (ja) 2010-09-24
AU743759B2 (en) 2002-02-07
DE69934108D1 (de) 2007-01-04
CN1263509C (zh) 2006-07-12
NO20005483L (no) 2000-12-08
NO20005483D0 (no) 2000-10-31
WO1999056772A2 (en) 1999-11-11
CZ301232B6 (cs) 2009-12-16
CZ20004061A3 (cs) 2001-04-11
CY1107322T1 (el) 2012-11-21
MY128929A (en) 2007-02-28
KR20010043224A (ko) 2001-05-25
TW553744B (en) 2003-09-21
HK1034202A1 (en) 2001-10-19
HU228209B1 (en) 2013-01-28
KR100612547B1 (ko) 2006-08-11
AU4137999A (en) 1999-11-23
ATE345815T1 (de) 2006-12-15
IL139269A0 (en) 2001-11-25
NZ507902A (en) 2002-03-28
ZA200006118B (en) 2002-01-30
TR200003235T2 (tr) 2001-03-21
PT1073462E (pt) 2007-01-31
DK1073462T3 (da) 2007-02-26
CA2331086A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
NZ323973A (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
CY1107457T1 (el) Εμβoλιο κατa του hpv
DZ2462A1 (fr) Vaccin antigrippal.
CY1112140T1 (el) Ανασυνδυασμενοι ιοι γριππης για εμβολια και γονιδιακη θεραπεια
DK0528859T3 (da) Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer
HRP20000181B1 (en) 2-methyl-thieno-benzodiazepine formulation
HUP0101047A1 (hu) Kombinált vakcinakészítmények
DK1113816T3 (da) Influenzavirus-vaccinesammensætning
DE69016956T2 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
DE69632235D1 (de) Newcastle-Krankheitsvirus-Kombinationsimpfstoff
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
MX9603896A (es) Vacuna para la prevencion de enfermedades respiratorias y reproductivas del cerdo, que contiene virus parainfluenza.
FR2728794B1 (fr) Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
DZ1706A1 (fr) Vaccin contre le virus de l'hepatite a.
FR2669346B1 (fr) Vaccin a poxvirus recombinant contre le virus de la rougeole.
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
HUP0101652A1 (hu) Új kompozíció
TW340873B (en) Chicken anaemia agent vaccine
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
EP0366238A3 (en) Influenza vaccinal polypeptides
BR9915946B1 (pt) formulaÇço de vacina para a administraÇço nasal compreendendo antÍgeno de superfÍcie do vÍrus da hepatite b (hbsag) e antÍgeno de nucleocapsÍdeo viral.
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
ES8800358A1 (es) Un procedimiento para preparar un polipeptido hibrido.